Diabetes Care 24:643-645, 2001
© 2001 by the American Diabetes Association, Inc.
Clinical Care/Education/Nutrition Original Article |
Mini-Dose Glucagon Rescue for Hypoglycemia in Children With Type 1 Diabetes
Morey W. Haymond, MD and
Barbara Schreiner, RN, MN, CDE
Texas Childrens Hospital Diabetes Care Center for Children and Adolescents, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
OBJECTIVEChildren with type 1 diabetes are frequently difficult to manage during times of gastroenteritis or poor oral intake of carbohydrates because of mild or impending hypoglycemia. The present study describes the effective use of small doses of subcutaneous glucagon in these children.
RESEARCH DESIGN AND METHODSWe analyzed 33 episodes of impending or mild hypoglycemia in 28 children (ages 6.6 ± 0.7 years). All were healthy except for type 1 diabetes and an episode of gastroenteritis. Using a standard U-100 insulin syringe, children ages 2 years received two "units" (20 µg) of glucagon subcutaneously and those ages >2 years received one unit/year of age up to 15 units (150 µg). If the blood glucose did not increase within 30 min, the initial dosage was doubled and given at that time. We used patients self-glucose monitoring devices, aqueous glucagon, standard insulin syringes, and frequent phone contact with a physician and/or a diabetes nurse educator in this study.
RESULTSBlood glucose was 3.44 ± 0.15 mmol/l before and 8.11 ± 0.72 mmol/l 30 min after glucagon. In 14 children, relative hypoglycemia recurred, requiring retreatment (3.48 ± 0.18 to 6.94 ± 0.72 mmol/l). In four children, a third dose was required. The glucagon was well tolerated. In 28 of the 33 episodes of impending hypoglycemia, the children remained at home and fully recovered. Five children were taken to their local hospital because of concerns of dehydration or fever, but none for hypoglycemia.
CONCLUSIONSMini-dose glucagon rescue, using subcutaneous injections, is effective in managing children with type 1 diabetes during episodes of impending hypoglycemia due to gastroenteritis or poor oral intake of carbohydrate.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Pearson
Glucagon as a Treatment of Severe Hypoglycemia: Safe and Efficacious but Underutilized
The Diabetes Educator,
January 1, 2008;
34(1):
128 - 134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev.,
February 1, 2007;
28(1):
84 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Heptulla, L. M. Rodriguez, L. Bomgaars, and M. W. Haymond
The Role of Amylin and Glucagon in the Dampening of Glycemic Excursions in Children With Type 1 Diabetes
Diabetes,
April 1, 2005;
54(4):
1100 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Silverstein, G. Klingensmith, K. Copeland, L. Plotnick, F. Kaufman, L. Laffel, L. Deeb, M. Grey, B. Anderson, L. A. Holzmeister, et al.
Care of Children and Adolescents With Type 1 Diabetes: A statement of the American Diabetes Association
Diabetes Care,
January 1, 2005;
28(1):
186 - 212.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jiang and B. B. Zhang
Glucagon and regulation of glucose metabolism
Am J Physiol Endocrinol Metab,
April 1, 2003;
284(4):
E671 - E678.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|